Would you have Sweating - excessive (Hyperhidrosis) when you have Multiple sclerosis?
Summary: Sweating - excessive is found among people with Multiple sclerosis, especially people who are female, 30-39 old, also have Depression, and take medication Avonex.
We study 1,253 people who have Sweating - excessive (Hyperhidrosis) and Multiple sclerosis from FDA and social media. Find out below who they are, other conditions they have and drugs they take.
You are not alone: join a mobile support group for people who have Multiple sclerosis and Sweating - excessive >>>
Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath) can be treated by Copaxone, Tysabri, Avonex, Rebif, Betaseron, Baclofen. (latest reports from 224,269 Multiple Sclerosis patients)
Sweating - excessive
Sweating - excessive (abnormally increased sweating) has been reported by people with depression, pain, high blood pressure, stress and anxiety, high blood cholesterol. (latest reports from 42,861 Sweating - excessive patients)
On Feb, 24, 2015: 1,253 people who have multiple sclerosis and Sweating - Excessive are studied.
Gender of people who have multiple sclerosis and experienced Sweating - excessive * :
|Sweating - excessive||76.91%||23.09% |
Age of people who have multiple sclerosis and experienced Sweating - excessive * :
|Sweating - excessive||0.00%||0.00%||0.53%||6.36%||19.83%||31.79%||32.40%||9.08% |
Severity of the symptom * :
|least||moderate||severe||most severe |
|Sweating - excessive||0.00%||28.57%||14.29%||57.14% |
Top co-existing conditions for these people * :
- Depression (44 people, 3.51%)
- Pain (27 people, 2.15%)
- Menopause (25 people, 2.00%)
- Gastrooesophageal reflux disease (25 people, 2.00%)
- Multiple allergies (21 people, 1.68%)
- Secondary progressive multiple sclerosis (21 people, 1.68%)
- Osteoporosis (21 people, 1.68%)
- Anaphylactic reaction (18 people, 1.44%)
- Hypertension (16 people, 1.28%)
- Anxiety (13 people, 1.04%)
Most common drugs used by these people * :
- Avonex (523 people, 41.74%)
- Tysabri (346 people, 27.61%)
- Rebif (238 people, 18.99%)
- Baclofen (106 people, 8.46%)
- Neurontin (88 people, 7.02%)
- Extavia (82 people, 6.54%)
- Gilenya (75 people, 5.99%)
- Betaseron (74 people, 5.91%)
- Copaxone (73 people, 5.83%)
- Vitamin d (47 people, 3.75%)
* Approximation only. Some reports may have incomplete information.
How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.
Get connected: join our support group of multiple sclerosis and sweating - excessive on
Do you have Multiple Sclerosis and Sweating - Excessive?
You are not alone! Join a mobile support group on :
- support group for people who have Sweating - Excessive and Multiple sclerosis
- support group for people who have Multiple sclerosis
- support group for people who have Sweating - Excessive
Could your drug cause:
Other conditions that could cause:
- A study of drug interactions between Flexeril, Cranberry, Vitamin D, Zyrtec, Lo Loestrin Fe, Tramadol, Adderall, Lyrica for a 37-year old woman with Muscle Spasms, Utis, Low D, Allergies, Endometriosis, Pain, Fatigue, Multiple Sclerosis. The patient has Hyperhidrosis
Recent Multiple Sclerosis related drug comparison:
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.